Evidence map›Paper›PMID 38515396›Full record

ArticleTechnology in cancer research & treatment

Determination of

Muhammet Ocak, Duygu Deniz Usta, Gokce Nur Arik Erol, Gulnur Take Kaplanoglu, Ece Konac, Atiye Seda Yar Saglam

Open access · goldAbstract read
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Muhammet OcakDepartment of Medical Biology and Genetics, Faculty of Medicine, Gazi University, Ankara, Turkey.
Duygu Deniz UstaDepartment of Medical Biology and Genetics, Faculty of Medicine, Gazi University, Ankara, Turkey.
Gokce Nur Arik ErolDepartment of Histology and Embryology, Faculty of Medicine, Gazi University, Ankara, Turkey.
Gulnur Take KaplanogluDepartment of Histology and Embryology, Faculty of Medicine, Gazi University, Ankara, Turkey.
Ece KonacDepartment of Medical Biology and Genetics, Faculty of Medicine, Gazi University, Ankara, Turkey.
Atiye Seda Yar SaglamDepartment of Medical Biology and Genetics, Faculty of Medicine, Gazi University, Ankara, Turkey.ORCID 0000-0002-9201-8464
Gazi University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Epithelial-Mesenchymal TransitionNeoplasmsAnimalsCaspase 3Cell Line, TumorCell MovementCell ProliferationEpirubicinFemaleMiceQuercetinRNA, MessengerCaspase 3EpirubicinQuercetinRNA, Messengertaxifolin4T1 cellsbreast cancerepirubicinepithelial–mesenchymal transitiontaxifolin

Identifiers

PMID38515396
PMCPMC10958820
OpenAlexW4393102260

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.